The anti-Runx2/SNAI2, anti-metastatic properties of E2 signaling in BCa cells may be relevant for early in vivo metastatic events, and possibly to targeting BCa metastasis to non-osseous tissues.
However, since lifestyle factors such as physical activity, dietary intake, and smoking habits affect the risk of developing MetS, it is important and possibly preferable to target lifestyle factors to prevent the onset of metabolic-related diseases in breast cancer survivors.
As for most protein protein interaction interfaces, the NEMO IKKβ interface is extended and prevalently flat and possibly difficult to target with small molecule inhibitors, but rational inhibitor design would greatly benefit from the knowledge of the structure of unliganded NEMO or NEMO in the presence of small molecule ligands.
FLP treatment combined with conventional therapies may possibly be used to target other NF-κB activated cancers, such as, glioblastoma.
Therefore, these data indicate that SCFFBXO28-mediated MYC ubiquitylation promotes MYC-driven transcription by facilitating recruitment of p300 and possibly other cofactors to target promoters.
A US military plan to survey refugee camps and aid agencies on the Pakistan-Afghanistan border, possibly to obtain targeting information for air strikes, sparked alarm among diplomats in Islamabad.
It is evident that much of our understanding of macrophage function comes from in vitro or small animal models and, while such knowledge is valuable, we have much to learn about the roles of the macrophage subsets in the clinical setting in order to identify the key pathways to target to possibly promote plaque stability.
In embryonic stem cells (ESCs), inactivation of SMARCA4 leads to defective self-renewal and promotes differentiation, while overexpression enhances the epigenetic reprogramming of fibroblasts into induced pluripotent stem (iPS) cells, possibly through increased OCT4 binding to target genes (Singhal et al., 2010).
The contribution of RARRES3 to differentiation over self-renewal suggests that reduced RARRES3 expression could be also predictive of therapy-resistant tumors, identifying patients possibly requiring new therapies designed to target breast cancer-initiating cells.
